Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2004 1
2005 7
2006 27
2007 30
2008 34
2009 46
2010 57
2011 48
2012 68
2013 124
2014 120
2015 156
2016 133
2017 165
2018 120
2019 82
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,071 results
Results by year
Filters applied: . Clear all
Page 1
GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.
Hermida MA, Dinesh Kumar J, Leslie NR. Hermida MA, et al. Adv Biol Regul. 2017 Aug;65:5-15. doi: 10.1016/j.jbior.2017.06.003. Epub 2017 Jun 27. Adv Biol Regul. 2017. PMID: 28712664 Review.
PI3K, AKT, and P-AKT levels in thin endometrium.
Le AW, Shan LL, Dai XY, Xiao TH, Li XR, Wang ZH, Zhang J, Chen XY. Le AW, et al. Genet Mol Res. 2016 Feb 5;15(1). doi: 10.4238/gmr.15017184. Genet Mol Res. 2016. PMID: 26909949 Free article.
LncRNA AK023948 is a positive regulator of AKT.
Koirala P, Huang J, Ho TT, Wu F, Ding X, Mo YY. Koirala P, et al. Nat Commun. 2017 Feb 8;8:14422. doi: 10.1038/ncomms14422. Nat Commun. 2017. PMID: 28176758 Free PMC article.
Signal transduction in cancer.
Sever R, Brugge JS. Sever R, et al. Cold Spring Harb Perspect Med. 2015 Apr 1;5(4):a006098. doi: 10.1101/cshperspect.a006098. Cold Spring Harb Perspect Med. 2015. PMID: 25833940 Free PMC article. Review.
Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors.
Davies BR, Guan N, Logie A, Crafter C, Hanson L, Jacobs V, James N, Dudley P, Jacques K, Ladd B, D'Cruz CM, Zinda M, Lindemann J, Kodaira M, Tamura K, Jenkins EL. Davies BR, et al. Mol Cancer Ther. 2015 Nov;14(11):2441-51. doi: 10.1158/1535-7163.MCT-15-0230. Epub 2015 Sep 8. Mol Cancer Ther. 2015. PMID: 26351323 Free article. Clinical Trial.
1,071 results
Jump to page
Feedback